Search
for

    Glossary Anthralin

    medication used to treat psoriasis and sometimes alopecia areata

    Anthralin, also known as Dithranol, is a medication commonly used to treat psoriasis and sometimes alopecia areata. It works by slowing down the growth of skin cells and reducing inflammation. While effective, it can cause skin irritation and staining, so it is typically applied under medical supervision.

    Related Terms

    Research 10 of 755

    1. Evaluation of Anthralin in the Treatment of Alopecia Areata Archives of dermatology · 1987 · 109 citations
    2. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: A retrospective case series Journal of the American Academy of Dermatology · 2015 · 44 citations
    3. Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin Archives of Dermatology · 1990 · 36 citations
    4. Anthralin/dithranol in dermatology International Journal of Dermatology · 2014 · 31 citations
    5. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin Experimental Dermatology · 2004 · 29 citations
    6. Comparison of Azelaic Acid and Anthralin for the Therapy of Patchy Alopecia Areata American Journal of Clinical Dermatology · 2005 · 27 citations
    7. Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata Pediatric dermatology · 2017 · 24 citations
    8. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series Archives of dermatological research · 2019 · 20 citations
    9. A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low‐level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow‐up based on clinical studies Journal of Cosmetic Dermatology · 2021 · 17 citations
    10. Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors? Pediatric dermatology · 2018 · 11 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →